Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
Ministerio de Sanidad y Consumo. Disponible en: http://www.msc.es/estadEstudios/estadisticas/inforRecopilaciones/atlas/atlasDatos.htm
[2.]
R.N. Anderson, B.L. Smith.
Deaths: leading causes for 2001.
Natl Vital Stat Rep, 52 (2003), pp. 1-85
[3.]
V. Vargas-Blasco.
Cirrosis hepática.
Medicina Interna, 2.a, pp. 1505-1524
[4.]
P. Farci, T. Roskams, L. Chessa, G. Peddis, A.P. Mazzoleni, R. Scioscia, et al.
Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis.
Gastroenterology, 126 (2004), pp. 1740-1749
[5.]
S.L. Friedman.
Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.
Physiol Rev, 88 (2008), pp. 125-172
[6.]
S.L. Friedman.
Mechanisms of hepatic fibrogenesis.
Gastroenterology, 134 (2008), pp. 1655-1669
[7.]
I.N. Hines, M.D. Wheeler.
Recent advances in alcoholic liver disease III. Role of the innate immune response in alcoholic hepatitis.
Am J Physiol Gastrointest Liver Physiol, 287 (2004), pp. G310-G314
[8.]
C.J. McClain, Z. Song, S.S. Barve, D.B. Hill, I. Deaciuc.
Recent advances in alcoholic liver disease III. Dysregulated cytokine metabolism in alcoholic liver disease.
Am J Physiol Gastrointest Liver Physiol, 287 (2004), pp. G497-G502
Copyright © 2012. Elsevier España S.L.. Todos los derechos reservados
